SENTAN PHARMA INC has a total of 13 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and foods and drinks are QIN XUEFANG, JIANGSU ANHUI BIO TECH CO LTD and VALBIOTIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | China | 1 | |
#6 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Fukuda Kotaro | 9 |
#2 | Nishina Sohji | 6 |
#3 | Hino Keisuke | 6 |
#4 | Sasaki Kyo | 6 |
#5 | Morinaga Hidetaka | 3 |
#6 | Ikemoto Hideki | 3 |
#7 | Matsuo Takeru | 3 |
#8 | Kinjo Ayano | 3 |
#9 | Egashira Kensuke | 3 |
#10 | Ogata Mika | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020189523A1 | Chemokine production promoter, therapeutic agent for immune checkpoint inhibitor-resistant cancer and antitumor immunostimulator | |
CN110831603A | Pharmaceutical composition and tumor immune activity promoter | |
WO2018038250A1 | Nanoparticles for addition to food product and method for producing nanoparticles for addition to food product | |
WO2018038267A1 | Poly(lactide-co-glycolide) copolymer nanoparticles, and method for producing poly(lactide-co-glycolide) copolymer nanoparticles | |
KR20170018969A | Pharmaceutical composition | |
EP2937087A1 | Composition and food or drink |